Kenneth Hall Hanger, Jr, MD

Dr. Jeffrey Winterfield is an associate professor of cardiac electrophysiology at the Medical University of South Carolina. He received his undergraduate degree from Amherst College in Massachusetts and his medical degree with honors from the University of Chicago Pritzker School of Medicine. He completed his internal medicine training at the University of Texas Southwestern Medical Center in Dallas. After completing his internal medicine residency, he was selected for a highly competitive fellowship in cardiovascular medicine at the Brigham and Women's Hospital, part of Harvard Medical School, in Boston. Dr. Winterfield's interest includes cardiac arrhythmias; he remained on service at the Brigham and Women's Hospital as a fellow in clinical cardiac electrophysiology where he trained with several leaders in the field. In 2011, he took his first faculty position in the prestigious heart rhythm program at Loyola University Medical Center in Chicago where he remained for five years. During that time in Chicago, he published multiple papers and abstracts, participated as a principal investigator in clinical trials regarding complex rhythm management, and served as faculty in national and international meetings. In 2016, he was recruited to MUSC for his expertise in catheter ablation of complex arrhythmias, particularly ventricular tachycardia (VT) and premature ventricular contractions (PVCs). He has special expertise in catheter ablation of arrhythmias on the outside of the heart (epicardial VT). Dr. Winterfield takes care of adult patients with cardiac rhythm disturbances including supraventricular tachycardia (SVT), Wolf-Parkinson-White (WPW), atrial fibrillation (AF), as well as premature ventricular contractions (PVCs) and ventricular tachycardia (VT). He has a particular interest in VT in patients with advanced heart disease including ischemic and non-ischemic cardiomyopathies.

Dr. Gary Gilkeson is a Distinguished University Professor of medicine/microbiology and immunology. He is also an Associate Dean for Faculty Affairs and Faculty Development. He received his undergraduate degree from Baylor University and his medical degree from the University of Texas Southwestern Medical School. He subsequently completed his internal medicine training at the University of North Carolina, Chapel Hill. Following four years as a Medical Officer in the Air Force, he completed a rheumatology fellowship at Duke University Medical Center in 1989. He joined the faculty of Duke at that time and achieved the position of Associate Professor of Medicine prior to moving to MUSC in 1996. Dr. Gilkeson is the author of over 250 publications and has received numerous honors including summa cum laude graduate of Baylor University and was a third-year Alpha Omega Alpha initiate at UT Southwestern. He has served on numerous NIH study sections and journal editorial boards. He has served on the national board of directors for both the Arthritis Foundation and the Lupus Foundation of America. He has served on numerous national committees for both the Arthritis Foundation, the American College of Rheumatology, and the Research and Education Foundation of the ACR. Dr. Gilkeson is past chair of the medical and scientific advisory board for the Lupus Foundation of America. His honors include receiving the MUSC Health Outstanding Clinician Award for 2007, a National Volunteer Service Award from the Arthritis Foundation, 2013 Peggy Schachte Research Mentor Award, 2016 American College of Rheumatology Award for Outstanding Investigational Mentoring, and was named 2017 Physician in Chief Pro-Tempore at the Hospital for Special Surgery in New York City. In 2018 he was named a Master of the American College of Rheumatology and as a Distinguished University Professor at MUSC. Dr. Gilkeson's research and clinical interests are both in lupus, particularly lupus nephritis. He also maintains a clinical interest in the disease retroperitoneal fibrosis. His clinical focus in lupus nephritis is the factors resulting in the ethnic disparity in outcomes in lupus comparing African Americans to Caucasians. He, along with Dr. Diane Kamen, has established the SLEIGH study, SLE in Gullah Health, to identify genetic and environmental factors that result in this disparity. Dr. Gilkeson's current major effort is in defining the safety and efficacy of umbilical cord derived mesenchymal stem cells for the treatment of refractory lupus in a multi center clinical trial of which MUSC is the directing center. Members of the M.U.S.C.L.E. Research Group at MUSC are studying transcriptional regulators in lupus, the role of the complement system in lupus and the role of estrogen receptors in lupus. The lupus research group is also identifying and validating new biomarkers in lupus and participants are active in the lupus genetics consortium defining genetic causes of lupus. The lupus research group is also involved in a number of clinical trials, both investigator-initiated and industry sponsored.

Dr. Emily Campbell grew up in a suburb of Cleveland, Ohio and received her BS from Miami University of Ohio where she majored in Zoology. She received her MD at the University of Toledo College of Medicine and went on to complete her residency in Pediatrics at Ann and Robert H. Lurie Children's Hospital of Chicago/McGaw Medical Center of Northwestern University. During her residency, Dr. Campbell developed a particular interest in food allergy. She completed her fellowship training in Allergy and Immunology at Vanderbilt University Medical Center. Her research during fellowship was primarily focused on mammalian meat allergy, or alpha gal allergy. Dr. Campbell sees patients of all ages. Her clinical interests include pediatric food allergy and pediatric eczema.